The higher education expenditure on R&D in medical and health sciences in Germany is projected to increase steadily over the next five years from 2024 to 2028, starting at 5.61 billion euros in 2024 and reaching 6.33 billion euros by 2028. Compared to 2023, which recorded an expenditure of 5.45 billion euros, this represents significant growth, indicating a healthy investment in this critical sector.
Year-on-year variations display a consistent upward trend, with the expenditure escalating by approximately 3.21% annually. The compound annual growth rate (CAGR) over the projected period is approximately 3.21%, reflecting robust commitments to advancing medical and health sciences through R&D.
Future trends to watch for:
- Increased investment driven by technology advancements in healthcare and personalized medicine.
- Potential budget reallocations in response to emergent global health challenges or economic shifts.
- Greater involvement of private-public collaborations to boost research outcomes.
- Impacts of policy changes promoting digital health transformations and sustainability in research initiatives.
